<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>Citicoline</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>Citicoline</h2><ul>
<li><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/6/64/Citicoline.svg/250px-Citicoline.svg.png"/></li>
<li>Pharmacological Actions</li>
<li>Citicoline’s pharmacological actions are multifaceted, primarily centered on supporting neuronal health and function:</li>
<ul>
<li>Enhancement of Phospholipid Synthesis: Citicoline acts as a precursor for phosphatidylcholine, crucial for maintaining the structural integrity of neuronal membranes. It is involved in the CDP-choline pathway, where it is converted into phosphatidylcholine via the enzyme diacylglycerol cholinephosphotransferase. This action is vital for membrane repair and maintenance, especially in conditions like ischemia where membrane integrity is compromised (<a href="https://en.wikipedia.org/wiki/Citicoline">source</a>).</li>
<li>Neuroprotective Effects: Citicoline exhibits neuroprotective properties through several mechanisms, including preservation of cardiolipin and sphingomyelin, restoration of phosphatidylcholine levels, and stimulation of glutathione synthesis, which has antioxidant effects. It also reduces phospholipase A2 activity and decreases arachidonic acid levels, particularly important post-ischemia to mitigate inflammation and cell damage. These effects are suggested to protect against neuronal injury in conditions like stroke and traumatic brain injury (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3933742/">source</a>).</li>
<li>Increase in Acetylcholine Synthesis: By providing choline, Citicoline supports the synthesis of acetylcholine, a neurotransmitter critical for memory, learning, and muscle control. This is particularly relevant in cognitive enhancement, as acetylcholine levels are often reduced in age-related cognitive decline. The brain preferentially uses choline for acetylcholine synthesis, which can limit availability for phospholipid synthesis, making Citicoline supplementation beneficial (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6683073/">source</a>).</li>
<li>Potential Modulation of Other Neurotransmitters: There is emerging evidence that Citicoline may increase brain levels of noradrenaline, dopamine, and serotonin, potentially explaining its antidepressant effects in some studies, though this is less robust and requires further research (<a href="https://www.sciencedirect.com/topics/neuroscience/citicoline">source</a>).</li>
</ul>
<li>Time Course of Actions</li>
<li>The time course for Citicoline’s pharmacological actions varies depending on the specific effect and condition:</li>
<ul>
<li>Phospholipid Synthesis and Neuroprotection: Given Citicoline’s rapid metabolism, with hydrolysis occurring within minutes in the liver, effects on phospholipid synthesis and neuroprotection likely begin within hours. In acute settings like stroke, administration within 24 hours is common, with outcomes such as reduced infarct size observed over days to weeks in animal models (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10548481/">source</a>).</li>
<li>Acetylcholine Synthesis: The increase in acetylcholine levels is likely to occur shortly after administration, potentially within hours, as Citicoline provides choline that can be rapidly utilized by cholinergic neurons. However, clinical cognitive benefits, such as improved memory, are typically observed after weeks of supplementation, with studies showing improvements after 12 weeks in older adults with memory impairment (<a href="https://www.healthline.com/health/citicoline">source</a>).</li>
<li>Long-Term Cognitive Effects: For chronic conditions like age-related cognitive decline, benefits are generally seen over extended periods, often requiring consistent daily intake for several weeks to months, as seen in trials like the IDEALE study (<a href="https://www.dovepress.com/the-role-of-citicoline-in-cognitive-impairment-pharmacological-charact-peer-reviewed-fulltext-article-CIA">source</a>).</li>
</ul>
<li>Half-Life and Bioavailability</li>
<li>Citicoline’s pharmacokinetics are complex due to its rapid metabolism:</li>
<ul>
<li>Half-Life: Citicoline itself has a very short plasma half-life, likely on the order of minutes, as it is quickly hydrolyzed in the intestine and liver into choline and cytidine. The elimination half-lives of its metabolites are reported as approximately 56 hours for CO2 via respiration and 71 hours for urinary excretion, reflecting the longer duration of metabolite clearance (<a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/citicoline">source</a>).</li>
<li>Bioavailability: Oral bioavailability is nearly 100%, with absorption being virtually complete, as noted in pharmacological reviews. This high bioavailability is comparable to intravenous administration, where bioavailability is 100% by definition. The drug is water-soluble, with minimal excretion in feces, supporting its efficient absorption (<a href="https://www.drugs.com/npp/citicoline.html">source</a>).</li>
</ul>
<li>Dosage Information</li>
<li>Dosage recommendations and safety profiles are well-established in clinical and supplemental use:</li>
<ul>
<li>Typical Doses: Doses range from 250 mg to 2000 mg per day, depending on the indication. For cognitive enhancement in healthy individuals, doses of 250–1000 mg per day are common, while for medical conditions like stroke, doses up to 2000 mg per day are used (<a href="https://www.healthline.com/health/citicoline">source</a>).</li>
<li>Safe Range: The safe range is considered up to 2000 mg per day, with clinical trials supporting this level without significant adverse effects. Data from meta-analyses show adverse event frequencies comparable to placebo at these doses (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3933742/">source</a>).</li>
<li>Minimum Effective Dose: The minimum effective dose varies by condition; for cognitive support, 250 mg per day may suffice, but effectiveness can depend on individual factors and specific studies, with some trials using 500 mg as a starting point (<a href="https://examine.com/supplements/cdp-choline/">source</a>).</li>
<li>Maximum Safe Dose: Doses up to 2000 mg per day are commonly used in clinical settings, with no significant safety concerns reported, suggesting this as the practical maximum safe dose (<a href="https://en.wikipedia.org/wiki/Citicoline">source</a>).</li>
<li>LD50: The lethal dose for 50% of subjects (LD50) is approximately 8 g/kg orally in rodents, indicating very low toxicity. For a 70 kg human, this translates to 560 g, far exceeding typical therapeutic doses, underscoring its safety profile (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3933742/">source</a>).</li>
<li>Dangerous Levels: Given the high LD50, Citicoline is unlikely to become dangerous at standard doses. Adverse effects are rare and mild, typically gastrointestinal, such as stomach pain and diarrhea, with no evidence of serious toxicity at therapeutic levels. Risks might emerge at doses in the grams per kilogram range, which are not relevant for human use (<a href="https://www.webmd.com/vitamins/ai/ingredientmono-1090/citicoline">source</a>).</li>
</ul>
</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main></body></html>